Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takao Kiyoi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Organic & Biomolecular Chemistry|March 11, 2011
Mannich-Michael versus formal aza-Diels-Alder approaches to piperidine derivativesP Ricardo Girling, Takao Kiyoi, Andrew Whiting
Journal of Medicinal Chemistry|September 16, 2021
Discovery of AS-1763: A Potent, Selective, Noncovalent, and Orally Available Inhibitor of Bruton's Tyrosine KinaseWataru Kawahata, Tokiko Asami, Takao Kiyoi, et al.
Progress in Medicinal Chemistry|May 16, 2006
Recent progress in cannabinoid researchJulia Adam, Phillip M Cowley, Takao Kiyoi, et al.
Journal of Medicinal Chemistry|September 15, 2018
Design and Synthesis of Novel Amino-triazine Analogues as Selective Bruton's Tyrosine Kinase Inhibitors for Treatment of Rheumatoid ArthritisWataru Kawahata, Tokiko Asami, Takao Kiyoi, et al.
Journal of Medicinal Chemistry|February 8, 2002
New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugsMasaaki Sawa, Takako Tsukamoto, Takao Kiyoi, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Design, synthesis, and structure-activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonistsTakao Kiyoi, Mark York, Stuart Francis, et al.
Cancers|July 20, 2021
Possible Therapeutic Strategy Involving the Purine Synthesis Pathway Regulated by ITK in Tongue Squamous Cell CarcinomaKaoru Onidani, Nami Miura, Yuki Sugiura, et al.
Bioorganic & Medicinal Chemistry|January 9, 2003
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitorsKazuya Yoshiizumi, Minoru Yamamoto, Tomohiro Miyasaka, et al.
Journal of Medicinal Chemistry|February 8, 2002
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acidsMasaaki Sawa, Takao Kiyoi, Kiriko Kurokawa, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonistsElizabeth M Moir, Kazuya Yoshiizumi, Jim Cairns, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Organic & Biomolecular Chemistry|March 11, 2011
Mannich-Michael versus formal aza-Diels-Alder approaches to piperidine derivativesP Ricardo Girling, Takao Kiyoi, Andrew Whiting
Journal of Medicinal Chemistry|September 16, 2021
Discovery of AS-1763: A Potent, Selective, Noncovalent, and Orally Available Inhibitor of Bruton's Tyrosine KinaseWataru Kawahata, Tokiko Asami, Takao Kiyoi, et al.
Progress in Medicinal Chemistry|May 16, 2006
Recent progress in cannabinoid researchJulia Adam, Phillip M Cowley, Takao Kiyoi, et al.
Journal of Medicinal Chemistry|September 15, 2018
Design and Synthesis of Novel Amino-triazine Analogues as Selective Bruton's Tyrosine Kinase Inhibitors for Treatment of Rheumatoid ArthritisWataru Kawahata, Tokiko Asami, Takao Kiyoi, et al.
Journal of Medicinal Chemistry|February 8, 2002
New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugsMasaaki Sawa, Takako Tsukamoto, Takao Kiyoi, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Design, synthesis, and structure-activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonistsTakao Kiyoi, Mark York, Stuart Francis, et al.
Cancers|July 20, 2021
Possible Therapeutic Strategy Involving the Purine Synthesis Pathway Regulated by ITK in Tongue Squamous Cell CarcinomaKaoru Onidani, Nami Miura, Yuki Sugiura, et al.
Bioorganic & Medicinal Chemistry|January 9, 2003
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitorsKazuya Yoshiizumi, Minoru Yamamoto, Tomohiro Miyasaka, et al.
Journal of Medicinal Chemistry|February 8, 2002
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acidsMasaaki Sawa, Takao Kiyoi, Kiriko Kurokawa, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonistsElizabeth M Moir, Kazuya Yoshiizumi, Jim Cairns, et al.
Pageof 2